Aldeyra Therapeutics's total assets for Q1 2025 were $93.20M, a decrease of -10.91% from the previous quarter. ALDX total liabilities were $29.60M for the fiscal quarter, a -11.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.